These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7460993)

  • 21. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C; Larsson L; Tiselius HG
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.
    Azoury R; Ramon J; Abrashkin S; Shalev J; Goldwasser B
    Urol Res; 1990; 18(1):7-11. PubMed ID: 2316076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples.
    Tiselius HG; Fornander AM
    Clin Chem; 1981 Apr; 27(4):565-8. PubMed ID: 7471423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of urine alkalization on excretion of renal citrate and degree of urine saturation with calcium oxalate in patients with calcium-oxalate urolithiasis and in healthy subjects].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Feb; 91(2):77-83. PubMed ID: 8008619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG; Ahlstrand C; Larsson L
    Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M; Roux JO; Bourelly F; Boularan AM; Guiter J; Monnier L
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2010 Jun; 75(6):1294-8. PubMed ID: 19914693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary citrate excretion in patients with urolithiasis and normal subjects.
    Nikkilä M; Koivula T; Jokela H
    Eur Urol; 1989; 16(5):382-5. PubMed ID: 2776809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate].
    Morimoto S
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 37. Diurnal variations of calcium, phosphorus, and magnesium in normal and calcium oxalate stone-forming urine.
    Ogawa Y; Kitagawa R; Umeyama T
    Nihon Jinzo Gakkai Shi; 1983 Sep; 25(9):1131-4. PubMed ID: 6686621
    [No Abstract]   [Full Text] [Related]  

  • 38. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
    Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
    Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.